Therefore, in both sensitive and resistant to BRAF inhibitor melanoma cells, mitochondria, and metabolism appear to be essential, and a drug, such as metformin or another biguanide, that alters this metabolism could be an interesting prospect for new melanoma treatments. Here, BRAF is linked to melanoma.